Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
Mrinal M. Patnaik, Raphaël Itzykson, Terra L. Lasho, et al.
Leukemia (2014) Vol. 28, Iss. 11, pp. 2206-2212
Closed Access | Times Cited: 257

Showing 1-25 of 257 citing articles:

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1676
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena, Anna Gallí, Esperanza Such, et al.
Blood (2016) Vol. 128, Iss. 10, pp. 1408-1417
Open Access | Times Cited: 300
Targeted deep sequencing in polycythemia vera and essential thrombocythemia
Ayalew Tefferi, Terra L. Lasho, Paola Guglielmelli, et al.
Blood Advances (2016) Vol. 1, Iss. 1, pp. 21-30
Open Access | Times Cited: 288
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Peter L. Greenberg, Richard M. Stone, Aref Al‐Kali, et al.
Journal of the National Comprehensive Cancer Network (2016) Vol. 15, Iss. 1, pp. 60-87
Open Access | Times Cited: 282
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Jane Merlevede, Nathalie Droin, Tingting Qin, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 201
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
Laura Palomo, Manja Meggendorfer, Stephan Hütter, et al.
Blood (2020) Vol. 136, Iss. 16, pp. 1851-1862
Open Access | Times Cited: 151
Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2022) Vol. 97, Iss. 3, pp. 352-372
Closed Access | Times Cited: 72
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2024) Vol. 99, Iss. 6, pp. 1142-1165
Open Access | Times Cited: 24
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic‐French Consortium Study
Emnet A Wassie, Raphaël Itzykson, Terra L. Lasho, et al.
American Journal of Hematology (2014) Vol. 89, Iss. 12, pp. 1111-1115
Open Access | Times Cited: 132
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies
Eric Padron, Guillermo Garcia‐Manero, Mrinal M. Patnaik, et al.
Blood Cancer Journal (2015) Vol. 5, Iss. 7, pp. e333-e333
Open Access | Times Cited: 129
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
Mrinal M. Patnaik, Ayalew Tefferi
Blood Cancer Journal (2016) Vol. 6, Iss. 2, pp. e393-e393
Open Access | Times Cited: 125
Age-related mutations and chronic myelomonocytic leukemia
Clinton C. Mason, Jamshid S. Khorashad, Srinivas K. Tantravahi, et al.
Leukemia (2015) Vol. 30, Iss. 4, pp. 906-913
Open Access | Times Cited: 124
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients
Sonia Cerquozzi, Daniela Barraco, Terra L. Lasho, et al.
Blood Cancer Journal (2017) Vol. 7, Iss. 12
Open Access | Times Cited: 122
Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2019) Vol. 95, Iss. 1, pp. 97-115
Open Access | Times Cited: 119
Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2018) Vol. 93, Iss. 6, pp. 824-840
Open Access | Times Cited: 111
How I treat chronic myelomonocytic leukemia
Éric Solary, Raphaël Itzykson
Blood (2017) Vol. 130, Iss. 2, pp. 126-136
Open Access | Times Cited: 106
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub
Rocco Piazza, Vera Magistroni, Sara Redaelli, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 103
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults
Raphaël Itzykson, Pierre Fenaux, David Bowen, et al.
HemaSphere (2018) Vol. 2, Iss. 6
Open Access | Times Cited: 103
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
Mrinal M. Patnaik, Terra L. Lasho, Pooja Vijayvargiya, et al.
Blood Cancer Journal (2016) Vol. 6, Iss. 1, pp. e385-e385
Open Access | Times Cited: 102
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients
Giacomo Coltro, Abhishek A. Mangaonkar, Terra L. Lasho, et al.
Leukemia (2019) Vol. 34, Iss. 5, pp. 1407-1421
Closed Access | Times Cited: 84
MDS overlap disorders and diagnostic boundaries
Tiffany Tanaka, Rafael Bejar
Blood (2019) Vol. 133, Iss. 10, pp. 1086-1095
Open Access | Times Cited: 80
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
Ryan M. Carr, Denis Vorobyev, Terra L. Lasho, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
ASXL1 mutations are frequent and prognostically detrimental in CSF3R‐mutated chronic neutrophilic leukemia
Michelle A. Elliott, Animesh Pardanani, Curtis A. Hanson, et al.
American Journal of Hematology (2015) Vol. 90, Iss. 7, pp. 653-656
Open Access | Times Cited: 86
Turning the tide in myelodysplastic/myeloproliferative neoplasms
Michael W. Deininger, Jeffrey W. Tyner, Éric Solary
Nature reviews. Cancer (2017) Vol. 17, Iss. 7, pp. 425-440
Closed Access | Times Cited: 76
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R
Ayalew Tefferi, Terra L. Lasho, Mrinal M. Patnaik, et al.
American Journal of Hematology (2017) Vol. 92, Iss. 12, pp. 1311-1317
Open Access | Times Cited: 74
Page 1 - Next Page

Scroll to top